Clozapine clinical trials

Explore recruiting clozapine clinical trials.

Recruiting clozapine studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Clozapine trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Assessment of clozapine-related immunodeficiency effect in Parkinson's disease patients (CLOZIDPD)

France

Therapeutic use (Phase IV) EU CTIS Study details

Biomarkers in clozapine-responding schizophrenia

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

An Adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, a D-Amino Acid Oxidase Inhibitor, as an Add-on Therapy with Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

Poland

Phase II and Phase III (Integrated) EU CTIS Study details

HAMLETT; Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A pragmatic single blind RCT of continuation versus discontinuation/ dose reduction of antipsychotic medication in patients remitted after a first episode of psychosis

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Does the glucagon-like peptide-1 receptor agonist semaglutide prevent deterioration of metabolic state in prediabetic or diabetic patients with schizophrenia treated with the antipsychotic compounds clozapine or olanzapine?

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major depressive disorder and bipolar depression compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.

Germany, Italy, Austria, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Clozapine trials by city

Clozapine in Toronto Clozapine in Vancouver Clozapine in Montreal Clozapine in Calgary Clozapine in Edmonton Clozapine in Ottawa Clozapine in Winnipeg Clozapine in Quebec City Clozapine in Hamilton Clozapine in Kitchener Clozapine in London Clozapine in Halifax Clozapine in New York Clozapine in Los Angeles Clozapine in Chicago Clozapine in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease